Cita APA (7a ed.)

Imoto, I., Saito, M., Suga, K., Kohmoto, T., Otsu, M., Horiuchi, K., . . . Masuda, K. (2021). Functionally confirmed compound heterozygous ADAM17 missense loss-of-function variants cause neonatal inflammatory skin and bowel disease 1. Nature Portfolio.

Cita Chicago Style (17a ed.)

Imoto, Issei, et al. Functionally Confirmed Compound Heterozygous ADAM17 Missense Loss-of-function Variants Cause Neonatal Inflammatory Skin and Bowel Disease 1. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Imoto, Issei, et al. Functionally Confirmed Compound Heterozygous ADAM17 Missense Loss-of-function Variants Cause Neonatal Inflammatory Skin and Bowel Disease 1. Nature Portfolio, 2021.